{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:47:30Z","timestamp":1790952450612,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Setsunan University"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.intimp.2018.06.014","type":"journal-article","created":{"date-parts":[[2018,6,14]],"date-time":"2018-06-14T06:33:28Z","timestamp":1528958008000},"page":"297-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Phenotype analyses of IL-10-producing Foxp3 \u2212  CD4 +  T cells increased by subcutaneous immunotherapy in allergic airway inflammation"],"prefix":"10.1016","volume":"61","author":[{"given":"Masaya","family":"Matsuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Morie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Oze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpei","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2018.06.014_bb0005","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1038\/35037000","article-title":"The epidemic of allergy and asthma","volume":"402","author":"Holgate","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2018.06.014_bb0010","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature07204","article-title":"The development of allergic inflammation","volume":"454","author":"Galli","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2018.06.014_bb0015","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.4049\/jimmunol.169.11.6482","article-title":"The role of IL-13 in established allergic airway disease","volume":"169","author":"Taube","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0020","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1398-9995.2007.01451.x","article-title":"Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study","volume":"62","author":"Jacobsen","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.intimp.2018.06.014_bb0025","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM199908123410702","article-title":"Long-term clinical efficacy of grass-pollen immunotherapy","volume":"341","author":"Durham","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2018.06.014_bb0030","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/j.1398-9995.2005.00960.x","article-title":"Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice","volume":"60","author":"Bonifazi","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.intimp.2018.06.014_bb0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13601-017-0160-0","article-title":"Allergen immunotherapy for allergic asthma: a systematic overview of systematic reviews","volume":"7","author":"Asamoah","year":"2017","journal-title":"Clin. Transl. Allergy"},{"key":"10.1016\/j.intimp.2018.06.014_bb0040","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ni1455","article-title":"Foxp3 in control of the regulatory T cell lineage","volume":"8","author":"Zheng","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0045","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/eji.200322919","article-title":"IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy","volume":"33","author":"Jutel","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0050","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nm.3179","article-title":"Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells","volume":"19","author":"Gagliani","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2018.06.014_bb0055","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaci.2013.12.1088","article-title":"Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens","volume":"133","author":"Akdis","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0060","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jaci.2007.07.046","article-title":"Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis","volume":"120","author":"Didier","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0065","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1365-2222.2012.03971.x","article-title":"Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety study","volume":"42","author":"Klimek","year":"2012","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.intimp.2018.06.014_bb0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.0019-2805.2001.01341.x","article-title":"IgG4 breaking the rules","volume":"105","author":"Aalberse","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2018.06.014_bb0075","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1084\/jem.20012024","article-title":"Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibody","volume":"195","author":"Azeredo Da Silveira","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2018.06.014_bb0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fc\u03b3 receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0085","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nature13868","article-title":"IgG1 protects against renal disease in a mouse model of cryoglobulinaemia","volume":"517","author":"Strait","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2018.06.014_bb0090","doi-asserted-by":"crossref","first-page":"887","DOI":"10.4049\/jimmunol.1401612","article-title":"IL-10 and regulatory T cells cooperate in allergen-specific immunotherapy to ameliorate allergic asthma","volume":"194","author":"B\u00f6hm","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0095","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jaci.2004.02.041","article-title":"Allergen immunotherapy induces a suppressive memory response mediated by IL-10 in a mouse asthma model","volume":"113","author":"Vissers","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2007.11.021","article-title":"Indoleamine 2,3-dioxygenase-dependent tryptophan metabolites contribute to tolerance induction during allergen immunotherapy in a mouse model","volume":"121","author":"Taher","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0105","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.4049\/jimmunol.0903909","article-title":"Suppression of Th2-driven airway inflammation by allergen immunotherapy is independent of B cell and Ig responses in mice","volume":"185","author":"Shirinbak","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0110","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri1370","article-title":"Therapeutic potential of oral tolerance","volume":"4","author":"Mayer","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0115","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.jaci.2014.07.052","article-title":"Immunologic characterization of 3 murine regimens of allergen-specific immunotherapy","volume":"135","author":"Fox","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0120","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejphar.2005.08.015","article-title":"Induction of a late asthmatic response associated with airway inflammation in mice","volume":"521","author":"Nabe","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0125","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1254\/jphs.11083FP","article-title":"Complete dependence on CD4+ cells in late asthmatic response, but limited contribution of the cells to airway remodeling in sensitized mice","volume":"116","author":"Nabe","year":"2011","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2018.06.014_bb0130","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.lfs.2011.04.003","article-title":"Important role of neutrophils in the late asthmatic response in mice","volume":"88","author":"Nabe","year":"2011","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2018.06.014_bb0135","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejphar.2011.12.020","article-title":"Regulatory role of antigen-induced interleukin-10, produced by CD4+ T cells, in airway neutrophilia in a murine model for asthma","volume":"677","author":"Nabe","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0140","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/bph.12154","article-title":"Roles of basophils and mast cells infiltrating the lung by multiple antigen challenges in asthmatic responses of mice","volume":"169","author":"Nabe","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0145","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejphar.2015.03.015","article-title":"Production of interleukin (IL)-33 in the lungs during multiple antigen challenge-induced airway inflammation in mice, and its modulation by a glucocorticoid","volume":"757","author":"Nabe","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0150","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2017.06.037","article-title":"Regulation of allergic airway inflammation by adoptive transfer of CD4+ T cells preferentially producing IL-10","volume":"812","author":"Matsuda","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0155","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1002\/eji.200838542","article-title":"Pulmonary stromal cells induce the generation of regulatory DC attenuating T-cell-mediated lung inflammation","volume":"38","author":"Li","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0160","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.4049\/jimmunol.170.5.2435","article-title":"Inhibition of Th2 differentiation and GATA-3 expression by BCL-6","volume":"170","author":"Kusam","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0165","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4049\/jimmunol.1501069","article-title":"Nonclassical CD4+ CD49b+ regulatory T cells as a better alternative to conventional CD4+ CD25+ T cells to dampen arthritis severity","volume":"196","author":"Vicente","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0170","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jaci.2010.11.025","article-title":"Wasp venom immunotherapy induces activation and homing of CD4+ CD25+ forkhead box protein 3-positive regulatory T cells controlling TH1 responses","volume":"127","author":"Kerstan","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0175","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/j.1365-2222.2012.04064.x","article-title":"Contribution of regulatory T cells to alleviation of experimental allergic asthma after specific immunotherapy","volume":"42","author":"Maazi","year":"2012","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.intimp.2018.06.014_bb0180","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.4049\/jimmunol.0901379","article-title":"Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation","volume":"184","author":"M\u00f6bs","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0185","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1084\/jem.20080193","article-title":"In vivo switch to IL-10\u2013secreting T regulatory cells in high dose allergen exposure","volume":"205","author":"Meiler","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2018.06.014_bb0190","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/exd.12295","article-title":"Continuous high-dose antigen exposure preferentially induces IL-10, but intermittent antigen exposure induces IL-4","volume":"23","author":"Yamanaka","year":"2014","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0195","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/ni738","article-title":"Damage control, rather than unresponsiveness, effected by protective DX5+ T cells in autoimmune diabetes","volume":"2","author":"Gonzalez","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0200","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.180.8.5211","article-title":"1Alpha, 25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-beta","volume":"180","author":"Taher","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0205","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1084\/jem.20051166","article-title":"Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+ CD25+ regulatory T cells is interleukin 10 dependent","volume":"202","author":"Kearley","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2018.06.014_bb0210","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jaci.2016.06.003","article-title":"Regulatory T cells in allergic diseases","volume":"138","author":"Noval Rivas","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0215","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.4049\/jimmunol.174.8.4718","article-title":"T regulatory-1 cells induce IgG4 production by B cells: role of IL-10","volume":"174","author":"Satoguina","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0220","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/187152806775269321","article-title":"Immunological mechanisms of specific allergen immunotherapy","volume":"5","author":"Schmidt-Weber","year":"2006","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"10.1016\/j.intimp.2018.06.014_bb0225","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cellimm.2013.06.014","article-title":"Antigen specific immunotherapy generates CD27+ CD35+ tolerogenic dendritic cells","volume":"283","author":"Wu","year":"2013","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0230","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaci.2017.03.045","article-title":"Allergen-specific IgG antibody signaling through Fc\u03b3RIIb promotes food tolerance","volume":"141","author":"Burton","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0235","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1172\/JCI117701","article-title":"Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors","volume":"95","author":"Daeron","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2018.06.014_bb0240","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0952-7915(98)80169-6","article-title":"Inhibitory signaling by B cell Fc gamma RIIb","volume":"10","author":"Coggeshall","year":"1998","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0245","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.immunol.19.1.275","article-title":"IgG Fc receptors","volume":"19","author":"Ravetch","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2018.06.014_bb0250","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/09680519020080060501","article-title":"Modulating macrophage function with IgG immune complexes","volume":"8","author":"Anderson","year":"2002","journal-title":"J. Endotoxin Res."},{"key":"10.1016\/j.intimp.2018.06.014_bb0255","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1084\/jem.188.1.217","article-title":"Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I","volume":"188","author":"Sutterwala","year":"1998","journal-title":"J. Exp. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918302650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918302650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T08:33:26Z","timestamp":1532594006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918302650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":51,"alternative-id":["S1567576918302650"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2018.06.014","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotype analyses of IL-10-producing Foxp3\u2212 CD4+ T cells increased by subcutaneous immunotherapy in allergic airway inflammation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2018.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}